The risk for reintroduction of some exotic vector-borne diseases in Europe has become a hot topic, while the reality of others is neglected at the public health policy level. Leishmaniasis is endemic in all southern countries of Europe, with approximately 700 autochthonous human cases reported each year (3,950 if Turkey is included). Asymptomatic cases have been estimated at 30-100/1 symptomatic case, and leishmaniasis has up to 25% seroprevalence in domestic dogs. Even though leishmaniasis is essentially associated with Leishmania infantum and visceral leishmaniasis, new species, such as L. donovani and L. tropica, might colonize European sand fly vectors. Drug-resistant L. infantum strains might be exported outside Europe through dogs. Despite this possibility, no coordinated surveillance of the disease exists at the European level. In this review of leishmaniasis importance in Europe, we would like to bridge the gap between research and surveillance and control.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600355PMC
http://dx.doi.org/10.3201/eid1407.071589DOI Listing

Publication Analysis

Top Keywords

vector-borne diseases
8
leishmaniasis europe
8
leishmaniasis
6
europe
5
spread vector-borne
4
diseases neglect
4
neglect leishmaniasis
4
europe risk
4
risk reintroduction
4
reintroduction exotic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!